[
    "Figure 1. Representative drug molecules containing trifluoromethyl groupand imdazazopyridine moiety,",
    "Figure 2. (a) Cyclic voltammetry of S1, (b) CV of CF5SO2Na, (c)CV of DMSO.Electrolyte LiCIO, in MeCN, glassy carbon disk as the working electrode and Pt wire as the counter electrode, Ag/AgCl reference electrode, scan rate0.1 Vs :",
    "Scheme 1. Electrochemical C3 trifluoromethylation of imidazol(1,2-dipyridines.",
    "Scheme 2. Substrate scope varying several 2-aminopyridines. [a] Standardconditions: S (0.3 mmol), CF3SO2Na (0,75 mmol), LiCIO4 (0:1 M), DMSO(4 mL), C canode, Pt cathode, undivided cell, constant current = 15 ma, at RTunder air for 2.5 h. [b] Isolated yield. [c] Electrolysis for 4 h 20 ma. [d]Electrolyysis for 5 h 25 ma.",
    "Scheme 3. Substrate scope varying phenyl ring; [a] Standard conditions: S(0.3 mmol), CF,SQ,Na (0.75 mmol), LiCIO, (01 M), DMSO (4 mL), Canode, Ptcathode, undivided cell, constant current = 15 mA, at RT under air for 2.5 h.[b] Isolated yield.",
    "Scheme 4: Preparation of trifluoromethylated benzozolifimidazol2(2)-bithiazole, gram scale electrosynthesis and synthetic derivatization.",
    "Scheme 5. Control experiments (ND: Not detected).",
    "Scheme 6. Plausible mechanism.",
    "Table 1. Optimization of the reaction conditions"
]